Our message at the CBD Expo, simplified, was “Labskin is the science for CBD product compliance!”. Labskin will offer CBD brands verifiable scientific data that backs up product claims without the cost of hiring a full-time microbiologist and major capital investment in a microbiology laboratory.
Rinocloud, a subsidiary of Integumen plc and sister company of Labskin, is proud to announce it has been shortlisted for an award from AI Awards Ireland.
On the 10th September 2019, the United States Environmental Protection Agency’s (EPA) Administrator Mr Andrew Wheeler signed a new directive to prioritise efforts to reduce and eliminate animal testing across the United States of America.
There is increasing interest in the development of non-invasive tools for studying the properties of skin, due to the potential for non-destructive sampling, reduced ethical concerns and the potential comparability of results in vivo and in vitro.
Cosmoprof is the leading trade show in the world for the entire cosmetics and professional beauty industry.
Labskin will be speaking at the 7th Microbiome R&D and Business Collaboration Forum in Rotterdam in May 2020.
Building a functional understanding of the microbiome to transform drug-discovery and improve health outcomes.
The annual event brings together industry and academia to discuss the challenges and opportunities in formulations and product development for skin, hair and oral care applications. The event covers a broad range of topics, enabling cross-sector fertilization.
The 2nd annual conference of Skin health and Dermatology as part of the Microbiome Movement was held in San Diego, California in September 2019. Labskin were proud to be both a sponsor and a speaker at the event.
But most of these models are sterile. In recent years, skin microbiota has emerged as a key player in skin health, preventing pathogens proliferation, educating the immune system and maintaining barrier integrity. The first skin models colonized with bacteria have focused on unique bacterial species. But the study of skin diseases (such as atopic dermatitis) revealed that microbiota’s diversity is key to skin health. We thus developed a model that reproduces the complexity of the skin’s ecosystem with an uncultured skin microbiota and compared it to the use of a unique commensal bacteria.
